Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

828794

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State, if he will take steps to ensure that people with diabetes are offered urine and blood tests to check for chronic kidney disease.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	124426
	answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published guidance on ‘Chronic kidney disease in adults’ which sets out best practice for clinicians on the diagnosis, treatment, care, and support of patients with chronic kidney disease (CKD). The guidance also includes recommendations for those at risk of developing CKD, including people with diabetes. NHS England expects commissioners to take account of NICE guidelines when delivering services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/01/2018 12:34:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

837539

	registered interest
	date	05/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Labelling
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make it his policy to introduce mandatory front of pack traffic light labelling for all pre-packaged food in the UK.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	126658
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>Mandatory nutrition labelling for the majority of pre-packaged foods came into effect in December 2016 and is harmonised by European Union legislation.</p><p> </p><p>The United Kingdom’s decision to leave the EU may give us an opportunity to develop greater flexibility, as the exit terms are agreed, to determine what information should be presented and how it should be displayed in the UK.</p><p> </p><p>There are ongoing discussions between officials in the Department of Health and Social Care and the Department for Environment, Food and Rural Affairs on the labelling of food and drink.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 126659 126660 question first answered 08/02/2018 15:22:02 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

791010

	registered interest
	date	16/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Primodos
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will bring forward proposals for a review of the findings of the Report of the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests, published in October 2017.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	113646
	answer	answer is ministerial correction date of answer 23/11/2017 answer text <p>The Commission on Human Medicines published the report of its Expert Working Group on Hormone Pregnancy Tests on 15 November 2017. Departmental ministers have accepted the report’s conclusions and recommendations.</p><p> </p><p>Based on its extensive and thorough review, the Expert Working Group’s overall finding, endorsed by the Commission on Human Medicines, is that the available scientific evidence, taking all aspects into consideration, does not support a causal association between the use of Hormone Pregnancy Tests, such as Primodos, during early pregnancy and adverse outcomes of pregnancy, including miscarriage, stillbirth or congenital anomalies. In addition to the overall conclusion, the Expert Working Group has made a number of recommendations to safeguard future generations through further strengthening the systems in place for detecting, evaluating, managing and communicating safety concerns associated with the use of medicines in early pregnancy.</p><p> </p><p>All the available relevant evidence on a possible association has been extensively and thoroughly reviewed with the benefit of up-to-date knowledge by experts from the relevant specialisms. There are no proposals for a review of the report’s findings and the Medicines and Healthcare products Regulatory Agency will now take forward the recommendations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2017 12:27:18 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1058753

	registered interest
	date	11/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the proposed amendments to the Human Medicines Regulation 2012, what treatment areas will be excluded from the serious shortage protocol for reasons of patient safety; and if he will publish a list of medicines and formulations that will be excluded as a result.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	219427
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, such protocols would not be suitable for medicines that need to be prescribed by brand for clinical reasons, such as biological medicines. In these cases, patients would always be referred to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:35:25 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1063789

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what process will be followed to consult with relevant health care professionals in the development of advice contained in a Serious Shortage Protocol.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222724
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1063790

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what methods the Government plans to use to whether a Serious Shortage Protocol is necessary; what information such a decision would be based on; what level of consultation with medical experts the Government plans to seek on such protocols; and how the Government plans to engage in such consultation.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222725
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222724 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1058754

	registered interest
	date	11/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulation 2019, what the system will be by which clinicians will be able to indicate whether or not an alternative (a) quantity, (b) strength, and (c) pharmaceutical form of medicine can be dispensed in line with the protocol; and how this system will be applied to regular repeat prescriptions.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	219428
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective. It can only be issued by Ministers and would only be introduced in the case of a serious shortage, if it would help manage the supply situation and if clinicians think it is appropriate, after discussion with the manufacturer and/or marketing authorisation holder.</p><p> </p><p>Any protocol would need to set out what alternative quantity, pharmaceutical form, strength, therapeutic equivalent or generic equivalent can be supplied. Supply in accordance with a protocol can only be made if the protocol is in date when a prescription is presented for dispensing, whether that prescription is an acute or a repeat prescription. If appropriate, the protocol could stipulate that it does not apply to a certain type of prescription.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:47:44 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

911141

	registered interest
	date	24/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the medical exemption criteria for prescription charges were first created; and how often that criteria has been (a) reviewed and (b) amended since it was introduced.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	147895
	answer	answer is ministerial correction date of answer 08/06/2018 answer text <p>Exemption from charges for people suffering from certain specified medical conditions started in June 1968 after an agreement with the medical professions.</p><p> </p><p>In 2008, Professor Sir Ian Gilmore, undertook a review into extending exemptions to all those with long-term conditions. The review was published in 2010, and in light of the financial challenges facing the country the decision was taken that no changes would be made. Since 1968, the only change to the list of medical exemption criteria was the introduction of the exemption for people undergoing cancer treatment in 2009, including the effects of cancer, or the effects of current or previous cancer treatment.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/06/2018 10:53:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

837541

	registered interest
	date	05/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to implement the commitment in the childhood obesity plan to review sugar labelling on pre-packaged foods.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	126660
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>Mandatory nutrition labelling for the majority of pre-packaged foods came into effect in December 2016 and is harmonised by European Union legislation.</p><p> </p><p>The United Kingdom’s decision to leave the EU may give us an opportunity to develop greater flexibility, as the exit terms are agreed, to determine what information should be presented and how it should be displayed in the UK.</p><p> </p><p>There are ongoing discussions between officials in the Department of Health and Social Care and the Department for Environment, Food and Rural Affairs on the labelling of food and drink.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 126658 126659 question first answered 08/02/2018 15:22:03 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

931114

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Vacancies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to fill vacant diagnostic positions in the NHS.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	157154
	answer	answer is ministerial correction date of answer 03/07/2018 answer text <p>In the Cancer Workforce Plan for England which was published in December 2017, Health Education England (HEE) set out the case for the need to target additional training support for clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p> </p><p>HEE will consider whether further action is required to increase supply beyond 2021 in the light of the longer-term health and care workforce strategy which is expected to be published by the end of this year.</p><p> </p><p>Locally, responsibility for assessing and managing staffing levels, including specialty staff, rests with individual National Health Service trusts and their boards who are best placed to decide how many staff they need to provide a given service.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 157156 question first answered 03/07/2018 13:10:53 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott